Compelling preclinical data in models of both GBA1-PD and idiopathic PD, demonstrating a disease-modifying effect after ...

MAIA Biotechnology, Inc., (NYSE American: MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that an abstract ...

A rare disease in the US is one in 1,500, or fewer than 200,000 people, and an ultra-rare disease is one in 50,000 or fewer ...

WALTHAM, Mass., March 28, 2025 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, today announced ...

As Baylor Genetics celebrates a decade of leadership at the forefront of genetic testing, it is set to exhibit its latest scientific studies in genetic testing at the 2025 ACMG Annual Clinical ...

Smartfood White Cheddar popcorn is the only snack I ever want. I mean this. I do not often crave sweets, and while I will happily accept chips and Cheetos and various Haldiram’s mixes, Smartfood is ...

Checkpoint Therapeutics, Inc. ("Checkpoint") (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, today announced financial ...

Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of the ...

A singer-songwriter who has one of the rarest conditions in the world has joined forces with the police to launch an access ...

The preclinical data are being presented at AAAAI/WAO in a poster presentation, entitled “Discovery and Characterization of a Novel Engineered Fc-fused IgE Cleaving Enzyme for Treatment of IgE ...

An 18-year-old singer-songwriter from Flintshire is helping police launch an access card for disabled people. Gracie Mellalieu, who lives in Mynydd Isa, is one of just 3,000 people across the globe ...